No weight loss in week 2 of Mounjaro — is that normal?

Step 1, understand what the 2.5 mg dose is actually for

The treatment starts at 2.5 mg for a reason. That first pen's job is adjustment: giving your gut and your nervous system time to get used to a dual GIP and GLP-1 receptor agonist before the dose climbs. It is not the dose at which most people experience meaningful appetite suppression, and it is not the dose the clinical trial results are based on. Expecting significant weight loss at week 2, on the starter level, is a bit like judging a journey by the first roundabout.

The NHS tirzepatide medicines page confirms this escalating schedule and explains that the prescriber moves the dose up in steps, typically every four weeks, according to how you are tolerating it. The therapeutic work begins to build from 5 mg onwards for most people, and continues through 7.5, 10, 12.5 and 15 mg. If you are curious about the broader picture of what weight loss on Mounjaro typically looks like across the full course, that context matters here.

The short version: no weight loss in week 2 of Mounjaro is not a sign that something has gone wrong. It is, for many people, exactly what week 2 looks like.

Step 2, account for what the scales are actually measuring

Body weight is not a clean measure of fat loss, especially in the first fortnight of any treatment. Water retention shifts with changes in diet, sodium intake and how much food is sitting in your digestive system at any given moment. Hormonal cycles add further noise for many women. Weighing yourself on a different day, at a different time, or after a salty meal can produce a swing of one to two kilograms that has nothing to do with the medicine.

This is worth sitting with. A reading of "no change" in week 2 might mask a small genuine reduction that is obscured by fluid. It might also reflect the normal plateau that follows the initial adjustment period. Either way, two data points (your starting weight and your week-2 weight) are not enough to draw conclusions. How long Mounjaro takes to work is a question worth reading through properly, because the honest answer involves a timeline measured in months, not days.

If you stepped on the scales first thing Monday morning the week you started, try to recreate those same conditions for every check-in going forward. Consistency in when and how you weigh matters more than frequency.

Step 3, look at what the trial evidence actually shows

The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed adults with obesity over 72 weeks. Average body-weight reduction reached around 20–21% at the 15 mg dose by the end of the study. That is a result built over a year and a half of treatment, not a fortnight. The trial did not report participants losing meaningful amounts in week 2 and the clinical literature does not describe that as a reasonable benchmark.

NICE's appraisal of tirzepatide (TA1026, published in December 2024) draws on this long-term evidence base when describing the medicine's benefits. The committee considered the full treatment trajectory, which involves slow-building appetite reduction as doses increase, not a rapid early drop. If you are in week 2 and feeling discouraged, the evidence suggests patience is well placed. Many people report that the most noticeable change in appetite and energy intake comes at 5 mg and above, weeks you have not reached yet.

For people who want to understand what typically happens in week 1, that page covers the very early picture. For those who are further along and still not seeing movement, the experience of no weight loss on Mounjaro more broadly is covered in detail separately.

When to flag something to your prescriber rather than waiting

Most people at week 2 should sit tight and let the dose do its job. But there are situations where a conversation with your prescriber is the right move sooner rather than later. If you are experiencing side effects that are stopping you from eating or drinking normally, that is worth reporting, not because weight loss is the priority, but because significant nausea, vomiting or diarrhoea can lead to dehydration and that needs clinical attention.

Similarly, if you felt no effects at all in week 1 or week 2 and you are wondering whether the pen was stored correctly or used properly, that is worth raising. A pen that was left out of the fridge for longer than the manufacturer's instructions allow, or one that was not injected correctly, would not behave as expected. Your Patient Information Leaflet covers storage and technique; your prescriber covers the clinical side. Our clinical team at nume is available for exactly these questions.

If you are further along in the titration and still not seeing any progress, you may find the page on no weight loss in week 3 or no weight loss in week 4 more relevant to your situation. And if you are weighing up the cost and structure of treatment alongside all of this, our Mounjaro cost page explains what a private prescription typically includes.

If you are not yet on treatment and are considering starting, you can speak to our prescribers through a free consultation, reviewed the same day by a named clinician, not a chatbot.